What OneCell Diagnostics does
Founded in 2021, OneCell Diagnostics operates in Health Tech offering precision oncology liquid biopsy diagnostics through its unique Circulating Tumor Cell-based, Single-Cell Multi-omics Lab Developed Tests. The company focuses on applications in clinical cancer care and supports early-stage clinical trials for Biotech and Pharma companies. OneCell Diagnostics is established as a joint venture between Actorius Innovations and Research Pvt Ltd and Indx.ai. Its mission is to leverage innovative technologies for advancing cancer diagnostics and treatment efficacy.
Who runs it
Funding and finances
Why this matters to you: funding stage is a rough proxy for how long the runway is and how much structure to expect. It is not a promise, and a profitable bootstrapped company can be the safer bet.
Check the company’s own careers page — linked at the top — before a job board. A role appears there first, sometimes weeks before it is syndicated anywhere else.
Questions and experiences
Nobody has asked anything about OneCell Diagnostics yet. If you have interviewed here, what you know is worth more to the next person than anything on the rest of this page.
Company facts compiled from public sources and last refreshed 9 September 2026. Details change; treat the company’s own site as the authority.